COMMUNIQUÉS West-GlobeNewswire

Arimoclomol for NPC receives Rare Pediatric Disease Designation

19/01/2018 - 08:16

Company announcement Orphazyme A/S No. 01/2018 Copenhagen, Denmark, January 19, 2018 – Orphazyme A/S, a Danish biotech company listed on Nasdaq Copenhagen (TICKER: ORPHA.CO), with a late-stage, orphan-drug pipeline, [...]

Motif Bio Announces Filing of U.S. Shelf Registration

19/01/2018 - 08:00

NEW YORK, Jan. 19, 2018 (GLOBE NEWSWIRE) -- Motif Bio® plc (AIM/NASDAQ:MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, today announced that the Company has filed a “ [...]

Bavarian Nordic Announces Initiation of Clinical Trial with Novel Cancer Immunotherapy Targeting Brachyury in Cancer Metastasis

19/01/2018 - 07:01

Brachyury plays a key role in metastasis and progression of tumors and is overexpressed in several major, as well as orphan cancers COPENHAGEN, Denmark, January 19, 2018 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) [...]

Santhera Plans to Announce Regulatory Feedback for Raxone® in DMD and 2017 Preliminary Key Financial Figures

19/01/2018 - 07:01

Liestal, Switzerland, January 19, 2018 - Santhera Pharmaceuticals (SIX: SANN) expects to announce feedback from the CHMP on its Marketing Authorization Application (MAA) for Raxone® in Duchenne muscular dystrophy (DMD) [...]

Obalon Therapeutics Prices Public Offering of Common Stock

19/01/2018 - 04:00

SAN DIEGO, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN ), a vertically integrated medical device company with the first and only FDA-approved swallowable, gas-filled intragastric balloon [...]

Agios Announces Pricing of $475 Million Public Offering of Common Stock

19/01/2018 - 02:43

CAMBRIDGE, Mass., Jan. 18, 2018 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO ) today announced that it has priced an underwritten public offering of 7,089,553 shares of common stock at a price to the [...]

HTG Molecular Diagnostics Announces Pricing of Public Offering of Common Stock

19/01/2018 - 01:29

TUCSON, Ariz., Jan. 18, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM ) (HTG), a provider of instruments, reagents and services for molecular profiling applications, today announced the pricing [...]

UroGen Pharma Announces Pricing of Public Offering of Ordinary Shares

19/01/2018 - 01:10

RA'ANANA, Israel and NEW YORK, Jan. 18, 2018 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN ), a clinical-stage biopharmaceutical company developing treatments to address unmet needs in the field of urology, with [...]

Diversicare to Present at the Noble Capital Markets’ Fourteenth Annual Investor Conference

18/01/2018 - 22:57

BRENTWOOD, Tenn., Jan. 18, 2018 (GLOBE NEWSWIRE) -- Diversicare Healthcare, Inc. (Nasdaq: DVCR ), a premier operator of long-term care services, today announced that its President and Chief Executive Officer, Kelly Gill [...]

Reata Announces the Publication of Efficacy Data From the Beacon Study of Bardoxolone in Diabetic CKD in the American Journal of Nephrology

18/01/2018 - 22:15

IRVING, Texas, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq: RETA ) (“Reata” or “the Company”), a clinical-stage biopharmaceutical company, today announced the digital publication of an original [...]

CBMG Accelerates Cell Therapy Manufacturing with GE Healthcare’s New Start-to-Finish Solution

18/01/2018 - 22:15

GE supports CBMG in its aim to speed up manufacturing timelines for its CAR T-cell therapy clinical trials and future commercialization First GE Healthcare FlexFactory™ for cell therapy installation in the world [...]

TRACON Pharmaceuticals Reports Granting of Inducement Awards

18/01/2018 - 22:05

SAN DIEGO, Jan. 18, 2018 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON ), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer [...]

Aeglea BioTherapeutics to Present Preclinical Data at 2018 Keystone Symposia Tumor Metabolism Conference

18/01/2018 - 22:05

AUSTIN, Texas, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE ), a biotechnology company committed to the discovery and development of engineered human enzyme therapeutics for patients with [...]

TiGenix: Transparency notification pursuant to Article 14 of the Law of May 2, 2007

18/01/2018 - 22:01

REGULATED INFORMATION PRESS RELEASE Transparency notification pursuant to Article 14 of the Law of May 2, 2007 Leuven (Belgium) - January 18, 2018, 22:00h CET - TiGenix NV (Euronext Brussels and Nasdaq: TIG; "TiGenix") [...]

109 Healthcare Groups Urge Congress to Immediately Reverse CMS Policy Linking Physician Payment Adjustments to Part B Drug Costs

18/01/2018 - 21:43

Washington, DC, Jan. 18, 2018 (GLOBE NEWSWIRE) -- More than 100 of the nation’s leading patient and provider organizations – including the American College of Rheumatology – are urging Congressional leaders to [...]

Phase 1b/2 Study of Margetuximab in Combination with Pembrolizumab Presented at 2018 ASCO Gastrointestinal Cancers Symposium

18/01/2018 - 20:00

Chemotherapy-free, immunotherapeutic combination evaluated 32% Overall response rate in second-line gastric cancer patients Well tolerated in dose escalation and expansion cohorts Rockville, MD, Jan. 18, 2018 (GLOBE [...]

Adherium Corporate Headquarters Opens in Silicon Valley

18/01/2018 - 19:37

SAN MATEO, Calif., Jan. 18, 2018 (GLOBE NEWSWIRE) -- Adherium (ASX:ADR), a digital health company that improves medication adherence and patient outcomes, today announced the opening of its corporate headquarters in San [...]

Sight-Restorative Eye Donations and Transplants in Colorado and Wyoming Break Records

18/01/2018 - 18:32

DENVER, Jan. 18, 2018 (GLOBE NEWSWIRE) -- The number of eye donations in Colorado and Wyoming, and the number of sight-restorative corneal transplants performed as a result, were at an all-time high in 2017. According [...]

NeuroMetrix, Inc. Announces Date for Fourth Quarter and Full Year 2017 Financial Results Conference Call

18/01/2018 - 17:40

WALTHAM, Mass., Jan. 18, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (NASDAQ: NURO ) announced today that it plans to issue its fourth quarter and full year 2017 financial results before the opening of the market on [...]